NANT CANCER IMMUNOTHERAPY Trademark

Trademark Overview

On Monday, October 22, 2018, a trademark application was filed for NANT CANCER IMMUNOTHERAPY with the United States Patent and Trademark Office. The USPTO has given the NANT CANCER IMMUNOTHERAPY trademark a serial number of 88164423. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 16, 2022. This trademark is owned by Nant Holdings IP, LLC. The NANT CANCER IMMUNOTHERAPY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer; pharmaceutical preparations for immunotherapy treatment; vaccines
nant cancer immunotherapy

General Information

Serial Number88164423
Word MarkNANT CANCER IMMUNOTHERAPY
Filing DateMonday, October 22, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 16, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer; pharmaceutical preparations for immunotherapy treatment; vaccines
Disclaimer with Predetermined Text"CANCER IMMUNOTHERAPY"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 2, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNant Holdings IP, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCulver City, CA 90232
Party NameNant Holdings IP, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCulver City, CA 90232

Trademark Events

Event DateEvent Description
Monday, May 16, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 16, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 18, 2021SOU EXTENSION 5 GRANTED
Monday, October 11, 2021SOU EXTENSION 5 FILED
Monday, October 18, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 11, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 9, 2021SOU EXTENSION 4 GRANTED
Friday, April 9, 2021SOU EXTENSION 4 FILED
Friday, April 9, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, October 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 9, 2020SOU EXTENSION 3 GRANTED
Friday, October 9, 2020SOU EXTENSION 3 FILED
Friday, October 9, 2020SOU TEAS EXTENSION RECEIVED
Saturday, April 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 9, 2020SOU EXTENSION 2 GRANTED
Thursday, April 9, 2020SOU EXTENSION 2 FILED
Thursday, April 9, 2020SOU TEAS EXTENSION RECEIVED
Saturday, September 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 26, 2019SOU EXTENSION 1 GRANTED
Thursday, September 26, 2019SOU EXTENSION 1 FILED
Thursday, September 26, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, April 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 7, 2019ASSIGNED TO LIE
Thursday, December 13, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 13, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, December 13, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 13, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, December 13, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, December 3, 2018ASSIGNED TO EXAMINER
Friday, November 2, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 25, 2018NEW APPLICATION ENTERED

Related Keywords

immunotherapy cancer nant pharmaceutical treatment preparations diagnosis prevention vaccines purposes medicinal